We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 42.6%
This Fund
S&P 500
This Quarter Est. Return
-3.94%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$375M
AUM Growth
-$24.9M
Cap. Flow
-$1.23M
Cap. Flow %
-0.33%
Top 10 Hldgs %
42.13%
Holding
166
New
12
Increased
40
Reduced
71
Closed
8

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$3.36M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.14M
3
ADMA icon
ADMA Biologics
ADMA
+$2.68M
4
SYM icon
Symbotic
SYM
+$1.5M
5
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$1.41M

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$3.3M
2
FMX icon
Fomento Económico Mexicano
FMX
+$3.13M
3
KVUE icon
Kenvue
KVUE
+$2.25M
4
IBM icon
IBM
IBM
+$2.13M
5
ALSN icon
Allison Transmission
ALSN
+$1.32M

Sector Composition

Rank Sector Weight
1 Financials 28.37%
2 Technology 18.88%
3 Healthcare 11.93%
4 Industrials 9.95%
5 Energy 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSX icon
101
CSX Corp
CSX
$93.1B
$413K 0.11%
14,048
– –
SLV icon
102
iShares Silver Trust
SLV
$30.7B
$404K 0.11%
13,040
-650
-5% -$18.9K
SYK icon
103
Stryker
SYK
$130B
$402K 0.11%
1,081
– –
DUK icon
104
Duke Energy
DUK
$97.3B
$387K 0.1%
3,172
-100
-3% -$11.4K
SANM icon
105
Sanmina
SANM
$10.9B
$381K 0.1%
5,000
– –
AMGN icon
106
Amgen
AMGN
$222B
$355K 0.09%
1,138
-50
-4% -$14.8K
CIVI
107
DELISTED
Civitas Resources
CIVI
$333K 0.09%
9,540
+400
+4% +$17.7K
CNX icon
108
CNX Resources
CNX
$5.2B
$315K 0.08%
10,000
– –
NBR icon
109
Nabors Industries
NBR
$1.21B
$313K 0.08%
7,500
+2,500
+50% +$127K
TCAF icon
110
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$8.29B
$312K 0.08%
9,675
+1,100
+13% +$36.9K
BCX icon
111
BlackRock Resources & Commodities Strategy Trust
BCX
$923M
$312K 0.08%
33,408
-12,559
-27% -$114K
MYCG
112
State Street My2027 Corporate Bond ETF
MYCG
$37.4M
$306K 0.08%
+12,285
New +$305K
DIS icon
113
Walt Disney
DIS
$181B
$300K 0.08%
3,038
-75
-2% -$8.06K
KVUE icon
114
Kenvue
KVUE
$36.9B
$294K 0.08%
12,277
-101,403
-89% -$2.25M
WAB icon
115
Wabtec
WAB
$49.3B
$285K 0.08%
1,569
+445
+40% +$85.3K
CI icon
116
Cigna
CI
$74.6B
$270K 0.07%
822
-12
-1% -$3.62K
HSY icon
117
Hershey
HSY
$36.6B
$270K 0.07%
+1,580
New +$259K
FNB icon
118
FNB Corp
FNB
$6.75B
$269K 0.07%
20,000
– –
PM icon
119
Philip Morris
PM
$295B
$268K 0.07%
1,687
– –
KEYS icon
120
Keysight
KEYS
$58.3B
$266K 0.07%
1,779
– –
MYCF
121
State Street My2026 Corporate Bond ETF
MYCF
$47.5M
$263K 0.07%
10,504
+537
+5% +$13.4K
COF icon
122
Capital One
COF
$134B
$257K 0.07%
1,434
– –
VYMI icon
123
Vanguard International High Dividend Yield ETF
VYMI
$20.9B
$257K 0.07%
3,483
-50
-1% -$3.59K
IBDQ
124
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$256K 0.07%
+10,175
New +$255K
SMRI icon
125
Bushido Capital US Equity ETF
SMRI
$662M
$255K 0.07%
8,270
+175
+2% +$5.59K
3 4
5
6 7

Similar funds

LI
Lafayette Investments Ashton, Maryland $494M AUM 11.42% 1-Year Est. Return
SAS
Stelac Advisory Services New York $494M AUM 23.25% 1-Year Est. Return
BFIC
Bedell Frazier Investment Counselling Walnut Creek, California $495M AUM 29.32% 1-Year Est. Return
FSA
Financial Sense Advisors San Diego, California $493M AUM 50.68% 1-Year Est. Return
TAM
Talaria Asset Management Melbourne, Australia $495M AUM 21.62% 1-Year Est. Return
TAA
Turiya Advisors Asia Hong Kong $496M AUM 75.42% 1-Year Est. Return
NYLIC
New York Life Insurance Company New York $491M AUM 10.97% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

Marathon Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Marathon Capital Management held 166 positions worth $375M, down 6.2% from $400M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Marathon Capital Management's Q1 2025 filing shows 12 new, 40 increased, 71 reduced and 8 closed positions. Its largest new stake was ADMA Biologics: 155,120 shares worth $3.08M. The largest sale was T. Rowe Price, an estimated $3.3M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 31% a quarter earlier, followed by Technology and Healthcare.

  • Marathon Capital Management's largest Q1 2025 buy was ADMA Biologics: 155,120 shares worth $3.08M.
  • Marathon Capital Management added most to Danaher in Q1 2025, an estimated $3.36M increase.
  • Marathon Capital Management's biggest Q1 2025 reduction was T. Rowe Price, cutting an estimated $3.3M.
  • Marathon Capital Management fully exited Fomento Económico Mexicano in Q1 2025, selling an estimated $3.13M.
  • Marathon Capital Management's ten largest holdings make up 42% of its $375M portfolio in Q1 2025.
  • Marathon Capital Management opened 12 new positions and closed 8 in Q1 2025.
  • Marathon Capital Management's portfolio value fell 6.2% quarter-over-quarter to $375M.

Based on Marathon Capital Management's 13F filing for Q1 2025, filed 15 May 2025.